华南预防医学 ›› 2022, Vol. 48 ›› Issue (2): 156-159.doi: 10.12183/j.scjpm.2022.0156

• 论著 • 上一篇    下一篇

中青年慢性肾脏病非透析患者共病现状分析

田瑞杰, 徐飒, 王荟苹, 史娟娟   

  1. 郑州大学第一附属医院,河南 郑州 450001
  • 收稿日期:2021-04-03 出版日期:2022-02-20 发布日期:2022-03-30
  • 通讯作者: 徐飒,E-mail:934488562@qq.com
  • 作者简介:田瑞杰(1983—),女,硕士研究生,副主任护师,主要从事慢性肾脏病管理
  • 基金资助:
    中华医学会杂志社2019年护理学科研究课题(CMAPH-NRI2019017)

Status of comorbidity in young and middle-aged non- dialyzed patients with chronic kidney disease

TIAN Rui-jie, XU Sa, WANG Hui-ping, SHI Juan-juan   

  1. The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450001, China
  • Received:2021-04-03 Online:2022-02-20 Published:2022-03-30

摘要: 目的 了解中青年慢性肾脏病非透析患者共病情况及其影响因素,为慢性肾脏病共病防治提供依据。方法 选取2020年1—8月在某三甲医院住院的中青年慢性肾脏病非透析患者,采用自行设计的一般资料调查表和疾病累积评分表进行共病状态评估。结果 最终纳入患者987例,以男性(59.8%)、18~44岁(53.2%)为主。中青年慢性肾脏病非透析患者共病率为85.3%,合并单病种以高血压(13.5%)、糖尿病(6.4%)、肝脏疾病(6.8%)、肺部感染(4.6%)最为多见,合并2种慢性病模式以高血压+糖尿病最为常见(6.3%)。疾病累积评分为7(5,9)分,882例(89.4%)处于轻度共病状态。性别(β'=-0.067)、年龄(β'=0.061)、共病种数(β'=0.622)是疾病累积评分的影响因素(P<0.05或P<0.01)。结论 中青年慢性肾脏病非透析患者共病情况不容忽视,卫生行政部门应提高对慢性病共病的管理意识,采取相应措施以提升中青年慢性肾病患者的健康水平。

关键词: 中青年, 慢性肾脏病, 共病, 高血压, 糖尿病

Abstract: Objective To understand the comorbidity of young and middle-aged non-dialyzed patients with chronic kidney disease (CKD) and its influencing factors, so as to provide basis for the prevention and control of CKD comorbidity. Methods Young and middle-aged non-dialyzed patients with CKD hospitalized in a hospital from January to August 2020 were selected to evaluate the comorbidity status by using the self-designed general information questionnaire and the cumulative illness rating scale (CIRS). Results A total of 987 patients were finally included, mainly male (59.8%) and 18-44 years old (53.2%). The prevalence of comorbidity in young and middle-aged non-dialyzed patients with CKD was 85.3%. Hypertension (13.5%), diabetes mellitus (6.4%), liver disease (6.8%) and pulmonary infection (4.6%) were the most common comorbidities. Hypertension and diabetes mellitus were the most common comorbidities in the two chronic disease modes (6.3%). The score of CIRS was 7 (5, 9), and 882 cases (89.4%) were in mild comorbidity. Gender (β'=-0.067), age (β'=0.061) and number of comorbidities (β'=0.622) were the influencing factors of CIRS score (P< 0.05 or P<0.01). Conclusion The comorbidity of young and middle-aged non-dialyzed patients with CKD can't be ignored. The health administrative department should improve the management awareness of chronic diseases and take corresponding measures to improve the health level of young and middle-aged patients.

Key words: Young and middle-aged, Chronic kidney disease, Comorbidity, Hypertension, Diabetes mellitus

中图分类号: 

  • R195